Sealed Air Corporation Opens New Global Manufacturing Facility for its Medical Products Group

DUNCAN, S.C. (Oct. 12, 2004) - Sealed Air Corporation today announced the opening of its new global manufacturing facility for its Medical Products Group with an official ribbon-cutting ceremony and open house in Duncan, S.C. The new facility is located at the site of the Sealed Air’s Cryovac Food Packaging Division and is the third Sealed Air manufacturing facility in the Upstate area.

The 20,000 square foot, free-standing building is designed for production in a "clean room" environment to produce the company’s complete line of pharmaceutical container materials and delivery systems, including its proprietary, non-PVC Cryovac® M312 flexible polyolefin film for pharmaceutical solutions applications. The building also is designed to be easily expanded for anticipated growth in this part of Sealed Air Corporation’s business.

"This state-of-the-art facility is a commitment to Sealed Air’s medical products business and an investment in the Duncan community," said Steve Schultz, vice president and general manager, global medical products for the Medical Products Group of Sealed Air Corporation. "Products manufactured in this facility will supply markets throughout the world including Asia, Europe and North America."

About Medical Products Division

A leading expert for more than 20 years in manufacturing films for ostomy applications, Sealed Air Corporation’s Medical Products Group continues to develop the next generation of pharmaceutical solutions containers for applications including parenteral nutrition, IV, irrigation, peritoneal dialysis, continuous ambulatory peritoneal dialysis (CAPD), antibiotics and specialty drugs.

The group’s intensive product development with leading pharmaceutical companies has resulted in a range of extremely tough, transparent and flexible polyolefin films and containers perfectly suited for sterile pharmaceutical solutions. Sealed Air’s medical films are manufactured in a controlled environment to minimize exposure to airborne particles. The pharmaceutical-solution contact surface is exposed to only Class-100 filtered air, which is defined as less than one hundred particles per cubic foot of air. Put into perspective, the air humans breathe generally has about one million particles per cubic foot. All products are produced under Good Manufacturing Practices (GMP) to assure the highest standard of quality.